{"id":936711,"date":"2026-02-12T18:14:53","date_gmt":"2026-02-12T23:14:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/"},"modified":"2026-02-12T18:14:53","modified_gmt":"2026-02-12T23:14:53","slug":"bbot-to-participate-in-upcoming-investor-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/","title":{"rendered":"BBOT to Participate in Upcoming Investor Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SOUTH SAN FRANCISCO, Calif., Feb.  12, 2026  (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months.<\/p>\n<p>\n        <strong>Details of the company\u2019s participation are as follows:<\/strong>\n      <\/p>\n<ul>\n<li>\n          <strong>Oppenheimer 36th Annual Healthcare Life Sciences Conference<br \/><\/strong>Presentation: Wednesday, February 25, 2026, at 10:40 a.m. ET.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Leerink Global Healthcare Conference<br \/><\/strong>Presentation: Tuesday, March 10, 2026, at 10:00 a.m. ET.<\/p>\n<\/li>\n<\/ul>\n<p>Live webcasts of the presentations will be accessible on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7jOC1hOjwxUxoPevLLHSZGUF3GGv4V5Ie0_uF3gl3AzB3xz4zQ3jUJNM1X4NdTWwS9TWWVuiPr0ihscpwESa67lRmrzx3HJERYbxq9hBzwk=\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u201d page of the BBOT website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KTmWjTnNy8_U5u1c03tIDNGwI9VTYT82X8M1ojjoKfJ0v0f8jJMRz3H-9XHfQs79HMT8FdOADTdulGzO6gUAnboxFTGXH-m6kGYz0Xbggy-UimdEXVrED3MSexpAMY8KE0gkyFd5KIJP0LK6qXsqBGtYxQgLKNgSUS9Dmay2B8A=\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.bbotx.com\/news-events\/events<\/a>. Replays of the webcasts will be available for at least 90 days following the event.<\/p>\n<p>\n        <strong>About BBOT<\/strong><br \/>\n        <br \/>BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K\u03b1 malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EwLAUor8gwdXcq5Fr9UV1JrHcGumBpZ1AcEgeg-7ZkMm8OzqEa07l9ibqJ5GJHXXHpz3itsD87nU8FXEwruu6g==\" rel=\"nofollow\" target=\"_blank\"><strong>www.bbotx.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=auqJI5XSfhq0NqSnF6XybuuQ4d3_SQiqmGUrb_Q6wCfImDlMrxN5bMHWz9W_r_D_Fg6o46BqH-loCl_BBv9xbHznRF9rA_3RimMQiqiLQkckhSPluiLS67xAzLZArpbi\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>.<\/p>\n<p>\n        <strong>BBOT Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Heather Armstrong <br \/>BBOT<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M3mzYp46VJwaidg2Ynq6kPNY0bMhnVUGGIVx2gclKwVV99tcqiB1CIXW9dyIk2oIq1iqLrIBUyeXjvOA_S9dODTOfJW4u8T3G-0mcnURdX1nGk9w7hroLTUXpkYpXLuK\" rel=\"nofollow\" target=\"_blank\"><strong>Heather.Armstrong@bbotx.com<\/strong><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Jake Robison<br \/>Inizio Evoke Comms<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mMuPN6aD5e80MzaFgXBOYxEFBkk1O1tXeUFSI4hSFlmjqGRCnC-0vGSD5ftjXZrmrblVG-jMcpBLF8CBJEYEa7dpU8Y6NSxf_LJxY4yGidjFf7c_YdVzbx7G2vhlqz_Z\" rel=\"nofollow\" target=\"_blank\"><strong>Jake.robison@inizioevoke.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjZkMTZhYTEtNDY1Yi00MDQ4LTlmNTMtZTc1NmI4MmU3YTJkLTEzMTQwNDctMjAyNi0wMi0xMi1lbg==\/tiny\/TheRas-Inc-d-b-a-BridgeBio-Onc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months. Details of the company\u2019s participation are as follows: Oppenheimer 36th Annual Healthcare Life Sciences ConferencePresentation: Wednesday, February 25, 2026, at 10:40 a.m. ET. Leerink Global Healthcare ConferencePresentation: Tuesday, March 10, 2026, at 10:00 a.m. ET. Live webcasts of the presentations will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. Replays of the webcasts will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BBOT to Participate in Upcoming Investor Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936711","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months. Details of the company\u2019s participation are as follows: Oppenheimer 36th Annual Healthcare Life Sciences ConferencePresentation: Wednesday, February 25, 2026, at 10:40 a.m. ET. Leerink Global Healthcare ConferencePresentation: Tuesday, March 10, 2026, at 10:00 a.m. ET. Live webcasts of the presentations will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. Replays of the webcasts will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing &hellip; Continue reading &quot;BBOT to Participate in Upcoming Investor Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T23:14:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BBOT to Participate in Upcoming Investor Healthcare Conferences\",\"datePublished\":\"2026-02-12T23:14:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"},\"wordCount\":198,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/\",\"name\":\"BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\",\"datePublished\":\"2026-02-12T23:14:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BBOT to Participate in Upcoming Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Oncology Therapeutics, Inc. (\u201cBBOT\u201d) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months. Details of the company\u2019s participation are as follows: Oppenheimer 36th Annual Healthcare Life Sciences ConferencePresentation: Wednesday, February 25, 2026, at 10:40 a.m. ET. Leerink Global Healthcare ConferencePresentation: Tuesday, March 10, 2026, at 10:00 a.m. ET. Live webcasts of the presentations will be accessible on the \u201cEvents\u201d page of the BBOT website at https:\/\/investors.bbotx.com\/news-events\/events. Replays of the webcasts will be available for at least 90 days following the event. About BBOT BBOT is a clinical-stage biopharmaceutical company advancing &hellip; Continue reading \"BBOT to Participate in Upcoming Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-12T23:14:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BBOT to Participate in Upcoming Investor Healthcare Conferences","datePublished":"2026-02-12T23:14:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/"},"wordCount":198,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/","name":"BBOT to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=","datePublished":"2026-02-12T23:14:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1Mzg0NyM3NDIzNjgxIzIzMDI0OTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bbot-to-participate-in-upcoming-investor-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BBOT to Participate in Upcoming Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936711"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936711\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}